12,930 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Modern Wealth Management LLC

Modern Wealth Management LLC bought a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 12,930 shares of the pharmacy operator’s stock, valued at approximately $129,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Walgreens Boots Alliance by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock valued at $805,506,000 after buying an additional 2,279,495 shares during the period. State Street Corp lifted its holdings in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after acquiring an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after purchasing an additional 2,185,950 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after purchasing an additional 817,762 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in shares of Walgreens Boots Alliance by 9.6% in the 4th quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock worth $50,684,000 after purchasing an additional 478,061 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Performance

WBA stock opened at $11.19 on Friday. The stock has a market cap of $9.67 billion, a P/E ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm has a 50 day simple moving average of $10.83 and a 200 day simple moving average of $9.90. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $21.74.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the business posted $0.66 EPS. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on WBA shares. Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Royal Bank of Canada boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Bank of America increased their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.